Literature DB >> 14534818

Treatment of pancreatic exocrine deficiency.

Martin Sarner1.   

Abstract

In treating pancreatic exocrine insufficiency the diagnosis of a cause, wherever possible, is a first step. If there is an obstructing lesion, then its relief may be curative. Adequate management depends on dietary manipulation and enzyme replacement. A reduction in fat intake, with accentuation of protein and carbohydrate consumption, is recommended. For enzyme replacement, enteric-coated microspheres are required, taken with adequate acid-suppression with a proton-pump inhibitor. The enzyme supplements, using standard preparations of pancreatin, usually of porcine source, may be as much as 4 to 8 tablets per meal and should be taken with food. Endocrine insufficiency usually requires insulin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534818     DOI: 10.1007/s00268-003-7237-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.

Authors:  P L Zentler-Munro; B A Assoufi; K Balasubramanian; S Cornell; D Benoliel; T C Northfield; M E Hodson
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

2.  Inactivation of human lipase by proteases.

Authors:  R Thiruvengadam; E P DiMagno
Journal:  Am J Physiol       Date:  1988-10

3.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  Salivary amylase in duodenal aspirates.

Authors:  G Skude; I Ihse
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

5.  High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

Authors:  S C FitzSimmons; G A Burkhart; D Borowitz; R J Grand; T Hammerstrom; P R Durie; J D Lloyd-Still; A B Lowenfels
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

6.  Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial.

Authors:  J Mössner; R Secknus; J Meyer; C Niederau; G Adler
Journal:  Digestion       Date:  1992       Impact factor: 3.216

7.  Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis.

Authors:  L Gullo; L Barbara; G Labò
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

8.  Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content.

Authors:  M Raimondo; E P DiMagno
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

9.  Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure.

Authors:  P T Regan; E P DiMagno
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

Review 10.  Pancreatic diabetes mellitus.

Authors:  R J Sjoberg; G S Kidd
Journal:  Diabetes Care       Date:  1989 Nov-Dec       Impact factor: 19.112

View more
  4 in total

1.  Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection.

Authors:  Yasuhiro Murata; Shugo Mizuno; Hiroyuki Kato; Masashi Kishiwada; Ichiro Ohsawa; Takashi Hamada; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Keisuke Nishimura; Kazuo Fukutome; Shuji Isaji
Journal:  Clin J Gastroenterol       Date:  2011-06-10

Review 2.  Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas.

Authors:  Raffaele Pezzilli; Angelo Andriulli; Claudio Bassi; Gianpaolo Balzano; Maurizio Cantore; Gianfranco Delle Fave; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

3.  Randomized placebo controlled clinical trial of an enteric coated micro-pelleted formulation of a pancreatic enzyme supplement in dogs with exocrine pancreatic insufficiency.

Authors:  Joseph Cyrus Parambeth; Geoffrey T Fosgate; Jan S Suchodolski; Jonathan A Lidbury; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

Review 4.  Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer.

Authors:  Raffaele Pezzilli; Riccardo Caccialanza; Gabriele Capurso; Oronzo Brunetti; Michele Milella; Massimo Falconi
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.